While Some Pharma Firms Contemplate A Move From Europe, Lilly Plants More R&D Roots
This article was originally published in The Pink Sheet Daily
Executive Summary
Pricing and reimbursement concerns in Europe could have a knock-on effect on R&D there, but with new academic tie-ups, Lilly says this is the time to invest.